Poland· PL-100201563
Alli
A orlistat product containing orlistatum, registered in Poland by GlaxoSmithKline Dungarvan Ltd.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Orlistat is registered in 16 of 19 countries.
Countries holding a registration under ATC A08AB01 (orlistat), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Orlistat · ATC A08AB01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of orlistat costs, country by country.
Normalised to the WHO defined daily dose (0.36 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Orlistat · price per daily dose (0.36 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.08
The record
At a glance
URPL (Poland)- Active substance
- Orlistatum
- Manufacturer
- GlaxoSmithKline Dungarvan Ltd.
- Country
- Poland (PL)
- ATC code
- A08AB01
- ATC class
- Orlistat
- Defined daily dose
- 0.36 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990672080
- gtin05909990672073
- gtin05909990672059
- gtin05909990672066
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
374 interactions on record for orlistat.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Orlistat · interactions on record
374 records
- 9 severe
- 117 moderate
- 8 minor
- 238 info
Most severe, free to view
- TriheptanoinA16AX17severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Orlistat in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALLIHALEON IRELAND DUNGARVAN LIMITED, Waterford
- SpainALLI 60 mg CAPSULAS DURASHaleon Ireland Dungarvan Limited
- FinlandAlliHaleon Ireland Dungarvan Limited
- BelgiumAlli 60 mgHaleon Ireland Dungarvan
- United KingdomAlli 60mg capsulesSigma Pharmaceuticals Plc
- United StatesALLIAphena Pharma Solutions - Tennessee, LLC
- Swedenalli 60 mg Kapsel, hårdHaleon Ireland Dungarvan Ltd
- NetherlandsAlli 60 mg, harde capsulesGlaxoSmithKline Dungarvan Limited
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Belgium · Orlistat Sandoz, Orlistat Teva
- Czechia · Orlistat 1 A Pharma, Orlistat Sandoz
- Germany · Orlistat 1 A Pharma, Orlistat Hexal
- Denmark · Orlistat Accord, Orlistat Rivopharm
- Estonia · Orlistat Sandoz
- Spain · Beacita, Elimens
- Finland · Orlistat Sandoz, Orlistat Stada
- France · Orlistat Eg
- United Kingdom (Northern Ireland) · Orlistat, Orlistat Accord-Uk
- Ireland · Orlistat Accord
- Iceland · Alli, Xenical
- Italy · Beacita
- Liechtenstein · Alli, Xenical
- Lithuania · Orlistat Polpharma
- Latvia · Orlistat Polpharma
- Netherlands · Orlistat Sandoz
- Norway · Alli, Orlistat Accord
- Portugal · Orlistato Beacita, Orlistato Ciclum
- Sweden · Beacita, Orlistat Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a3b0804-b259-4213-b83d-72d893823f89 GET /v1/drugs/9a3b0804-b259-4213-b83d-72d893823f89?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "60 mg",
"packaging": "05909990672059 ¦ OTC ¦ EU/1/07/401/007 ¦ 46861\n42 kaps.\n05909990672066 ¦ OTC ¦ EU/1/07/401/008 ¦ 46862\n60 kaps.\n05909990672073 ¦ OTC ¦ EU/1/07/401/009 ¦ 46863\n84 kaps.\n05909990672080 ¦ OTC ¦ EU/1/07/401/010 ¦ 46864\n90 kaps.\nOTC ¦ EU/1/07/401/011 ¦ 88251\n120 kaps.",
"substance": "Orlistat 60 mg",
"common_name": "Orlistatum",
"pl_product_id": "100201563",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about orlistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.